APMRF yields 883.39% · JNJ yields 2.13%● Live data
📍 APMRF pulled ahead of the other in Year 1
Combined, APMRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of APMRF + JNJ for your $10,000?
Amper, S.A. provides industrial and technological solutions in Madrid and internationally. The company offers deployments of the FTTH fiber optic and mobile networks. It is also involved in the provision of design, manufacture, and assembly of installations for the control of atmospheric pollution; development of security systems for signal intelligence, protection of critical infrastructures, and identification and certification; and design and manufacture of devices to connect to the Internet for various fields, such as the digital home, smart cities, industry, and logistics, as well as software development. In addition, the company offers emergencies and critical mission communication systems solutions comprising command, control, communications, computer, coordination, and intelligence applied to public security control centers and the smaller desk centers for local community management; and integrated solutions for the design, calculations, engineering, supply, construction, and assemble of big structures in various industrial areas. Amper, S.A. was founded in 1956 and is based in Madrid, Spain.
Full APMRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.